Eastman Chemical (EMN) rises 3.4% as investors focus on 2026 self-help plan and cash-return commitments

Eastman Chemical Company (EMN) is up 3.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears to be tied to investors revisiting Eastman’s 2026 improvement plan laid out with its latest quarterly results, including stepped-up cost reductions, expected utilization improvements, and benefits from its Kingsport methanolysis ramp. With no single, company-specific headline clearly circulating today, the gain also looks consistent with a sentiment-driven bounce after the company emphasized cash generation and ongoing capital returns.

Details:

In its latest results package, Eastman highlighted 2025 operating cash flow approaching $1 billion and about $500 million returned to stockholders through dividends and share repurchases.

Management outlined 2026 priorities that include continued dividends, capital spending, and share repurchases while maintaining an investment-grade balance sheet.

The company said it is increasing planned cost-structure reduction actions to a range of $125 million to $150 million for 2026.

Eastman pointed to improved operational performance at its Kingsport methanolysis facility as a key driver of incremental earnings and a pillar of its innovation-led growth strategy.

Sources:

Eastman

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$EMN Hedge Fund Activity

We have seen 292 institutional investors add shares of $EMN stock to their portfolio, and 495 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. added 5,746,631 shares (+72.2%) to their portfolio in Q4 2025, for an estimated $366,807,456
INVESCO LTD. removed 2,266,616 shares (-77.2%) from their portfolio in Q4 2025, for an estimated $144,678,099
CAPITAL WORLD INVESTORS removed 1,857,386 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $118,556,948
STATE STREET CORP removed 1,820,270 shares (-32.0%) from their portfolio in Q4 2025, for an estimated $116,187,834
HIGHTOWER ADVISORS, LLC added 1,648,054 shares (+3448.7%) to their portfolio in Q4 2025, for an estimated $105,195,286
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,263,573 shares (-83.2%) from their portfolio in Q4 2025, for an estimated $80,653,864
GEODE CAPITAL MANAGEMENT, LLC removed 1,104,577 shares (-35.8%) from their portfolio in Q4 2025, for an estimated $70,505,149

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$EMN Analyst Ratings

Wall Street analysts have issued reports on $EMN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Keybanc issued a "Overweight" rating on 01/09/2026
Citigroup issued a "Buy" rating on 12/18/2025
UBS issued a "Buy" rating on 11/05/2025
Wells Fargo issued a "Overweight" rating on 09/16/2025

To track analyst ratings and price targets for $EMN, check out Quiver Quantitative's $EMN forecast page.

$EMN Price Targets

Multiple analysts have issued price targets for $EMN recently. We have seen 10 analysts offer price targets for $EMN in the last 6 months, with a median target of $73.5.

Here are some recent targets:

Patrick Cunningham from Citigroup set a target price of $84.0 on 03/12/2026
Stephen Richardson from Evercore ISI Group set a target price of $75.0 on 02/18/2026
David Begleiter from Deutsche Bank set a target price of $72.0 on 02/02/2026
Steve Byrne from B of A Securities set a target price of $79.0 on 02/02/2026
Jeffrey Zekaukas from JP Morgan set a target price of $70.0 on 02/02/2026
Arun Viswanathan from RBC Capital set a target price of $70.0 on 01/16/2026
Aleksey Yefremov from Keybanc set a target price of $74.0 on 01/09/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.